Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-25-000084
Filing Date
2025-01-02
Accepted
2025-01-02 16:09:40
Documents
1
Period of Report
2025-01-02

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 3722
  Complete submission text file 0001127602-25-000084.txt   5403
Mailing Address 2445 TECHNOLOGY FOREST BLVD. SUITE 1100 THE WOODLANDS TX 77381
Business Address 2445 TECHNOLOGY FOREST BLVD. SUITE 1100 THE WOODLANDS TX 77381 2818633000
LEXICON PHARMACEUTICALS, INC. (Issuer) CIK: 0001062822 (see all company filings)

EIN.: 760474169 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 101 POOR FARM ROAD 3RD FLOOR PRINCETON NJ 08540
Business Address
Coiante Scott M (Reporting) CIK: 0001608536 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-30111 | Film No.: 25502109